You are here

  • Home
  • Archive
  • Volume 10, Issue 12
  • Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer

Article info

Article menu
Immunotherapy biomarkers
Original research
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer

Authors

  • Misha Mao Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Yongxia Chen Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Jingjing Yang Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Yifan Cheng Department of Gastrointestinal Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China PubMed articlesGoogle scholar articles
  • Ling Xu Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Feiyang Ji Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Jichun Zhou Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Xun Zhang Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Zhaoqing Li Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Cong Chen Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Siwei Ju Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Jiahang Zhang Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles
  • Linbo Wang Department of Surgical Oncology, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, Hangzhou, ChinaZhejiang university, Zhejiang, Hangzhou, China PubMed articlesGoogle scholar articles

Citation

Mao M, Chen Y, Yang J, et al
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer
Journal for ImmunoTherapy of Cancer 2022;10:e005668. doi: 10.1136/jitc-2022-005668
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.